Response to letter re: Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers

被引：0
|
作者：
Blay, J. -y. [1 ,2 ,3 ]
Brahmi, M. [1 ,2 ,3 ]
Dufresne, A. [1 ,2 ,3 ]
Heudel, P. [1 ,2 ]
机构：
[1] Ctr Leon Berard, Lyon, France
[2] Univ Claude Bernard Lyon I, Lyon, France
[3] Ctr Rech Cancerol Lyon, Equipe 4, Lyon, France
来源：
ESMO OPEN | 2025年 / 10卷 / 04期
关键词：
INTERLEUKIN-6;
D O I：
10.1016/j.esmoop.2025.104531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 29 条
  • [1] Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers
    Blay, J. -y.
    Brahmi, M.
    Dufresne, A.
    Swalduz, A.
    Avrillon, V.
    Assaad, S.
    Decroisette, C.
    Mastroianni, B.
    Dupont, M.
    Bourbotte-Salmon, F.
    Ray-Coquard, I.
    Meeus, P.
    Dutour, A.
    Castets, M.
    Perol, M.
    Heudel, P.
    ESMO OPEN, 2025, 10 (01)
  • [2] Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
    Miho Suzuki
    Misato Hashizume
    Hiroto Yoshida
    Masahiko Mihara
    Rheumatology International, 2010, 30 : 309 - 315
  • [3] Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
    Suzuki, Miho
    Hashizume, Misato
    Yoshida, Hiroto
    Mihara, Masahiko
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (03) : 309 - 315
  • [4] Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
    Xu, Jiuhui
    Chen, Chenglong
    Sun, Kunkun
    Shi, Qianyu
    Wang, Boyang
    Huang, Yi
    Ren, Tingting
    Tang, Xiaodong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Treatment of Brain Dead Donors with Anti-IL-6R mAb Attenuates the Inflammatory Immune Response
    Reutzel-Selke, A.
    Beiglboeck, F.
    Velikova, M.
    Marksteiner, M.
    Polenz, D.
    Neuhaus, P.
    Kotsch, K.
    Pratschke, J.
    TRANSPLANTATION, 2012, 94 (10) : 455 - 455
  • [6] Treatment of Brain Dead Donors with Anti-IL-6R Monoclonal Antibody Attenuates the Early Inflammatory Immune Response
    Reutzel-Selke, Anja
    Velikova, Mariya
    Beiglboeck, Fabian
    Marksteiner, Marion
    Polenz, Dietrich
    Neuhaus, Peter
    Kotsch, Katja
    Pratschke, Johann
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 218 - 218
  • [7] Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
    Rubsamen, Reid
    Burkholz, Scott
    Massey, Christopher
    Brasel, Trevor
    Hodge, Tom
    Wang, Lu
    Herst, Charles
    Carback, Richard
    Harris, Paul
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [8] Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
    Hashizume, Misato
    Mihara, Masahiko
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (04) : 397 - 401
  • [9] Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
    Misato Hashizume
    Masahiko Mihara
    Rheumatology International, 2009, 29 : 397 - 401
  • [10] TREATMENT OF BRAIN DEAD DONORS WITH ANTI-IL-6R MONOCLONAL ANTIBODY ATTENUATES THE EARLY AND LATE INFLAMMATORY IMMUNE RESPONSE
    Reutzel-Selke, A.
    Beiglboeck, F.
    Velikova, M. P.
    Marksteiner, M.
    Polenz, D.
    Neuhaus, P.
    Kotsch, K.
    Pratschke, J.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 45 - 46
123